GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » IMAC Holdings Inc (NAS:BACK) » Definitions » ROE %

IMAC Holdings (IMAC Holdings) ROE % : 0.00% (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is IMAC Holdings ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. IMAC Holdings's annualized net income for the quarter that ended in Mar. 2024 was $-1.63 Mil. IMAC Holdings's average Total Stockholders Equity over the quarter that ended in Mar. 2024 was $-1.00 Mil. Therefore, IMAC Holdings's annualized ROE % for the quarter that ended in Mar. 2024 was N/A%.

The historical rank and industry rank for IMAC Holdings's ROE % or its related term are showing as below:

BACK's ROE % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 4.32
* Ranked among companies with meaningful ROE % only.

IMAC Holdings ROE % Historical Data

The historical data trend for IMAC Holdings's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IMAC Holdings ROE % Chart

IMAC Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE %
Get a 7-Day Free Trial -168.51 -62.16 -81.83 -162.03 -483.27

IMAC Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -523.94 -1,759.25 -3,417.64 -4,241.45 -

Competitive Comparison of IMAC Holdings's ROE %

For the Medical Care Facilities subindustry, IMAC Holdings's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IMAC Holdings's ROE % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, IMAC Holdings's ROE % distribution charts can be found below:

* The bar in red indicates where IMAC Holdings's ROE % falls into.



IMAC Holdings ROE % Calculation

IMAC Holdings's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=-9.419/( (4.651+-0.753)/ 2 )
=-9.419/1.949
=-483.27 %

IMAC Holdings's annualized ROE % for the quarter that ended in Mar. 2024 is calculated as

ROE %=Net Income (Q: Mar. 2024 )/( (Total Stockholders Equity (Q: Dec. 2023 )+Total Stockholders Equity (Q: Mar. 2024 ))/ count )
=-1.628/( (-0.753+-1.239)/ 2 )
=-1.628/-0.996
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2024) net income data. ROE % is displayed in the 30-year financial page.

* Note that if the average Total Stockholders Equity is zero or negative, then ROE % would be considered meaningless and hence not be calculated.


IMAC Holdings  (NAS:BACK) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Mar. 2024 )
=Net Income/Total Stockholders Equity
=-1.628/-0.996
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-1.628 / 0)*(0 / 1.0275)*(1.0275 / -0.996)
=Net Margin %*Asset Turnover*Equity Multiplier
=N/A %*0*N/A
=ROA %*Equity Multiplier
=N/A %*N/A
=N/A %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Mar. 2024 )
=Net Income/Total Stockholders Equity
=-1.628/-0.996
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-1.628 / -1.796) * (-1.796 / -1.636) * (-1.636 / 0) * (0 / 1.0275) * (1.0275 / -0.996)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.9065 * 1.0978 * N/A % * 0 * N/A
=N/A %

Note: The net income data used here is four times the quarterly (Mar. 2024) net income data. The Revenue data used here is four times the quarterly (Mar. 2024) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


IMAC Holdings ROE % Related Terms

Thank you for viewing the detailed overview of IMAC Holdings's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


IMAC Holdings (IMAC Holdings) Business Description

Traded in Other Exchanges
N/A
Address
3401 Mallory Lane, Suite 100, Franklin, TN, USA, 37067
IMAC Holdings Inc is a company operating a chain of Integrated Medicine and Chiropractic (IMAC) Regeneration Centers, combining life science advancements with traditional medical care for movement restricting diseases and conditions. It owns and manages outpatient clinics that provide regenerative, orthopedic, and minimally invasive procedures and therapies. Its primary service areas are located in certain geographical areas in the states of Florida, Illinois, Kentucky, Louisiana, Missouri, and Tennessee.
Executives
Benjamin S Lerner officer: Chief Operating Officer C/O IMAC HOLDINGS, INC., 1605 WESTGATE CIRCLE, BRENTWOOD TN 37027
Matthew C Wallis director, 10 percent owner, officer: Chief Operating Officer C/O IMAC HOLDINGS, INC., 1605 WESTGATE CIRCLE, BRENTWOOD TN 37027
Michael D Pruitt director 11220 ELM LANE, SUITE 203, CHARLOTTE NC 28277
Cary Sucoff director 1612 EAST CAPE CORAL PKWY, C/O LEGACY EDUCATION ALLIANCE, INC., CAPE CORAL FL 33904
Maurice E. Evans director C/O IMAC HOLDINGS, INC., 1605 WESTGATE CIRCLE, BRENTWOOD TN 37027
Jeffrey S Ervin director, officer: Chief Executive Officer C/O IMAC HOLDINGS, INC., 1605 WESTGATE CIRCLE, BRENTWOOD TN 37027
Hayden Gerard M Jr director C/O PRIVATE BUSINESS INC, P O BOX 1603, BRENTWOOD TN 37024
David Ellwanger director C/O IMAC HOLDINGS, INC., 1605 WESTGATE CIRCLE, BRENTWOOD TN 37027
Sheri Gardzina officer: Interim CFO C/O IMAC HOLDINGS, INC., 1605 WESTGATE CIRCLE, BRENTWOOD TN 37027
George P Hampton director C/O HORIZON PHARMA PLC, 520 LAKE COOK ROAD, STE 520, DEERFIELD IL 60015
Dean Weiland director C/O IMAC HOLDINGS, INC., 1605 WESTGATE CIRCLE, BRENTWOOD TN 37027
Dwight Anthony Bond officer: Chief Financial Officer C/O IMAC HOLDINGS, INC., BRENTWOOD TN 37027